428 related articles for article (PubMed ID: 11820912)
1. Benefits and risks of inhaled corticosteroids in chronic obstructive pulmonary disease.
Bonay M; Bancal C; Crestani B
Drug Saf; 2002; 25(1):57-71. PubMed ID: 11820912
[TBL] [Abstract][Full Text] [Related]
2. The risk/benefit of inhaled corticosteroids in chronic obstructive pulmonary disease.
Bonay M; Bancal C; Crestani B
Expert Opin Drug Saf; 2005 Mar; 4(2):251-71. PubMed ID: 15794718
[TBL] [Abstract][Full Text] [Related]
3. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
Hanania NA
Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
[TBL] [Abstract][Full Text] [Related]
4. Should inhaled corticosteroids be used in the long term treatment of chronic obstructive pulmonary disease?
Burge S
Drugs; 2001; 61(11):1535-44. PubMed ID: 11577791
[TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a long-term benefit?
Highland KB
Curr Opin Pulm Med; 2004 Mar; 10(2):113-9. PubMed ID: 15021180
[TBL] [Abstract][Full Text] [Related]
6. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
[TBL] [Abstract][Full Text] [Related]
7. Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease.
Sin DD; Man SF
Drugs Aging; 2003; 20(12):867-80. PubMed ID: 14565780
[TBL] [Abstract][Full Text] [Related]
8. The role of corticosteroids in chronic obstructive pulmonary disease.
Calverley PM
Semin Respir Crit Care Med; 2005 Apr; 26(2):235-45. PubMed ID: 16088440
[TBL] [Abstract][Full Text] [Related]
9. Steroid therapy in chronic obstructive pulmonary disease.
OBrien A; Ward NS
Med Health R I; 2002 Feb; 85(2):52-5. PubMed ID: 11881166
[TBL] [Abstract][Full Text] [Related]
10. Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a clinical benefit?
Man SF; Sin DD
Drugs; 2005; 65(5):579-91. PubMed ID: 15748094
[TBL] [Abstract][Full Text] [Related]
11. A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo.
Soriano JB; Sin DD; Zhang X; Camp PG; Anderson JA; Anthonisen NR; Buist AS; Burge PS; Calverley PM; Connett JE; Petersson S; Postma DS; Szafranski W; Vestbo J
Chest; 2007 Mar; 131(3):682-689. PubMed ID: 17356080
[TBL] [Abstract][Full Text] [Related]
12. Impact of long-term treatment with low-dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: aggravating or beneficial?
Mathioudakis AG; Amanetopoulou SG; Gialmanidis IP; Chatzimavridou-Grigoriadou V; Siasos G; Evangelopoulou E; Mathioudakis GA
Respirology; 2013 Jan; 18(1):147-53. PubMed ID: 22985270
[TBL] [Abstract][Full Text] [Related]
13. [The place of inhaled corticosteroids in COPD].
Chinet T; Dumoulin J; Honore I; Braun JM; Couderc LJ; Febvre M; Mangiapan G; Maurer C; Serrier P; Soyez F; Terrioux P; Jebrak G
Rev Mal Respir; 2016 Dec; 33(10):877-891. PubMed ID: 26831345
[TBL] [Abstract][Full Text] [Related]
14. Is there a role for systemic corticosteroids in the management of stable chronic obstructive pulmonary disease?
Wood-Baker R
Am J Respir Med; 2003; 2(6):451-8. PubMed ID: 14719984
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
16. Use of inhaled corticosteroids in COPD: improving efficacy.
Yang IA; Shaw JG; Goddard JR; Clarke MS; Reid DW
Expert Rev Respir Med; 2016; 10(3):339-50. PubMed ID: 26855301
[TBL] [Abstract][Full Text] [Related]
17. Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary disease.
Donohue JF; Ohar JA
Proc Am Thorac Soc; 2004; 1(3):152-60. PubMed ID: 16113428
[TBL] [Abstract][Full Text] [Related]
18. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials.
Alsaeedi A; Sin DD; McAlister FA
Am J Med; 2002 Jul; 113(1):59-65. PubMed ID: 12106623
[TBL] [Abstract][Full Text] [Related]
19. [Role of inhaled corticosteroids in the management of COPD].
Chazan R
Pneumonol Alergol Pol; 2009; 77(2):186-91. PubMed ID: 19462354
[No Abstract] [Full Text] [Related]
20. Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978].
Sin DD; Man SF; Marciniuk DD; Ford G; FitzGerald M; Wong E; York E; Mainra RR; Ramesh W; Melenka LS; Wilde E; Cowie RL; Williams D; Rousseau R;
BMC Pulm Med; 2006 Feb; 6():3. PubMed ID: 16460562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
